With ACTCD's Tufts dog trial reports, it would not surprise me if we bounced up to fill in the gap at $11.14 kept going past $12.04 and never looked back. Maybe wishfull thinking maybe truth. Hope the best for everyone. People have had plenty of time to cover IMO new investors, please do your own DD.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.